Background/Aims: Current drug therapies for osteoarthritis (OA) are not practical because of the cytotoxicity and severe side-effects associated with most of them. Artemisinin (ART), an antimalarial agent, is well known for its safety and selectivity to kill injured cells. Based on its anti-inflammatory activity and role in the inhibition of OA-associated Wnt/β-catenin signaling pathway, which is crucial in the pathogenesis of OA, we hypothesized that ART might have an effect on OA. Methods: The chondro-protective and antiarthritic effects of ART on interleukin-1-beta (IL-1β)-induced and OA patient-derived chondrocytes were investigated in vitro using cell viability assay, glycosaminoglycan secretion, immunofluorescence, quantitative reverse transcription-polymerase chain reaction, and western blotting. We also used OA model rats constructed by anterior cruciate ligament transection and medial meniscus resection (ACLT+MMx) in the joints to investigate the effects of ART on OA by gross observation, morphological staining, immunohistochemistry, and enzyme-linked immunosorbent assay. Results: ART exhibited potent anti-inflammatory effects by inhibiting the expression of proinflammatory chemokines and cytokines, including interleukin (IL)-1β, IL-6, tumor necrosis factor alpha, and matrix metallopeptidase-13. It also showed favorable chondro-protective effect as evidenced by enhanced cell proliferation and viability, increased glycosaminoglycan
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Introduction
Osteoarthritis (OA) is one of the most painful, prevalent articular disorders that affects 10%-15% of adults, and it becomes a burden to patients, communities, and health and social care systems [1] . Osteoarthritis is characterized by progressive articular cartilage degeneration, synovial inflammation, and subchondral bone damage. Currently, effective therapy for OA is limited. Non-pharmacologic and non-surgical therapies, including therapeutic ultrasound and terminal isometric exercises, are introduced to treat OA [2] . Current therapy for OA is based on a sequential hierarchical approach, with non-steroidal anti-inflammatory drugs (NSAIDs) as the leading treatment option [3] . Although they exhibit effective pain reduction, the treatment with NSAIDs is limited by complications such as gastroenteropathy, ease of suppression, limited clinical remission rate, immunity, and secondary tumors [4, 5] . An alternative is natural anti-inflammatory agents derived from plants and herbs, such as olive oil, icariin, and angelica polysaccharides, which have potential to prevent cartilage degeneration in patients with OA [6, 7] .
Artemisinin (ART) is a sesquiterpene lactone isolated from the Chinese plant Artemisia annua (commonly known as qinghaosu or sweet wormwood) in 1970 by Youyou Tu, who was awarded the Nobel Prize in Physiology or Medicine in 2015 [8] . Artemisinin and its derivatives are currently identified as the most effective drugs to treat chloroquine-resistant [9, 10] . In addition, with minimal side effects and nonresistant characteristics, ART can selectively kill parasite-infected red blood cells, but preserve the healthy cells [11, 12] . This unique pharmacological mechanism endows ART distinct advantages of efficacy and safety in clinical application. Besides the anti-malarial functions, ART family drugs also exhibit anti-tumor [13] [14] [15] , anti-viral [16] , anti-inflammatory, and immune-suppressive activities [17, 18] . Artemisinin has been reported to abolish germinal center B cells and inhibit autoimmune arthritis in the K/BxN mouse model of rheumatoid arthritis [19] . SM905, a kind of ART derivative, ameliorates collagen-induced arthritis by suppressing inflammatory response [20] . These findings indicate that ART might have potential in the treatment of joint inflammation in patients with OA, which should be further verified.
Evidence also suggests that ART exerts anti-inflammatory and anti-tumor effects by suppressing the Wnt/β-catenin signaling pathway, which is well established as a crucial pathway regulating the pathogenesis of OA [21, 22] . The canonical Wnt pathway triggers its signaling within chondrocytes by regulating intracellular level and subcellular localization of β-catenin [23, 24] . As a pivotal factor in the noncanonical Wnt pathway, Wnt5a can also activate canonical β-catenin signaling, which contributes to the therapeutic effect on OA [25] . Conditional activation of β-catenin by Wnt5a in articular chondrocytes from adult mice leads to premature chondrocyte differentiation and development OA-like phenotype development, including progressive loss of articular cartilage matrix and formation of osteophytes [26, 27] . Given the importance of Wnt/β-catenin signaling pathway in OA progression, Wnt/β-catenin antagonists, such as sclerostin (SOST) and verapamil, are used to treat OA [28] . Thus, the ART drugs might be developed as novel Wnt/β-catenin antagonist for OA.
In this study, we explored the effect of ART on OA and its association with Wnt/β-catenin signaling by evaluating cell apoptosis-and inflammation related-markers in OA chondrocytes derived from interleukin (IL)-1β-induced animal models or human patients. Further investigation on the effects of ART on OA in vivo was also carried out using the joints
IL-1β-induced chondrocytes
To investigate the effects of ART on IL-1β-induced chondrocytes of rat, three groups were formed: (1) normal group, chondrocytes without any treatment; (2) IL-1β group, chondrocytes treated with IL-1β (10 ng/ml, Gibco, USA); and (3) IL-1β+ART group, chondrocytes pre-incubated with ART at the optimal dose for 1 h, followed by stimulation with IL-1β for 48 h. The OA patient-derived chondrocytes were treated with ART at the optimal dose for 2, 4, and 6 d, respectively. To study the association of ART with the Wnt/β-catenin signaling pathway, 10 mM lithium chloride (LiCl) (Shanghai Macklin Biochemical Co. Ltd, China), an activator of the Wnt signaling pathway, was introduced. 
Quantification of intracellular glycosaminoglycan (GAG) secretion
Chondrocytes treated with ART was harvested using proteinase K (Tiangen, China) for digestion. The enzymatic hydrolysates were used in the subsequent biochemical assays as previously described [30] . DNA content was determined by using the Hoechst 33258 (Sigma) method and detected with a spectrofluorometer at 360 (excitation) and 460 nm (emission), with calf thymus DNA as the standard. The secretion of intracellular glycosaminoglycan (GAG) was measured by the 1, 9-dimethylmethylene blue (DMMB; Sigma) assay. The total intracellular GAG secreted in each sample was detected at 525 nm with chondroitin sulfate (Sigma) as the standard. Eventually, the content of GAG was normalized to the total DNA content in chondrocytes.
Immunofluorescence staining
The secretion of IL-β, TNF-ɑ, BAX, and CASP-3 was detected by immunofluorescence in strict accordance with the instructions. To visualize protein, chondrocytes from rat or human were fixed in 4% (w/v) paraformaldehyde and treated with Triton X-100. To exclude endogenous peroxidase activity, chondrocytes were treated with 3% peroxide for 10 min at 25℃. The cells were blocked with normal goat serum for 10 min at room temperature. The samples were incubated with primary antibodies, including IL-β (Polyclonal, BOSTER, Wuhan, China; 1:200), TNF-ɑ (Polyclonal, BOSTER; 1:200), BAX (Polyclonal, BOSTER; 1:200), and CASP-3 (Polyclonal, BOSTER; 1:200) overnight at 4°C. The specimens were then incubated with the secondary antibody IgG-CY3 (BOSTER; 1:100) for 2 h at 37°C in dark. Eventually, the samples were observed and photographed with an inverted phase contrast microscope (Olympus BX53).
RNA extraction and quantitative real-time PCR
The intracellular total RNA was extracted using a Hipure Total RNA Mini kit (Magen, China), according to the manufacturer's instructions. Approximately 1000 ng of the extracted RNA was used as a template and reverse transcribed into cDNA using the PrimeScript™ RT reagent Kit with gDNA Eraser (Takara, China). The quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was performed using a LightCycler ® 480 (Roche, Germany) with a FastStart Universal SYBR Green Master Mix (Roche, Germany) under the following conditions: 10 min at 95°C, 15 s at 95°C, and 1 min at 60°C. The melting curve data were used to verify the specificity of PCR. The relative expression level of genes (IL-1β, IL-6, TNF-ɑ, MMP-13, caspase-3, BAX, β-catenin, FRZB, Wnt5a, LRP5/6 and GSK-3β) was determined by the 2 -ΔΔCt method. The level of target mRNA was normalized to that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and compared with that of the control. 
Table 1. Primer Sequences Used in qRT-PCR Experiments
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Western blotting
The total protein from chondrocytes was extracted using a total protein extraction kit, according to the manufacturer's instructions (BOSTER). The concentration of proteins was determined using the BCA Protein Assay reagent (Beyotime, China). Approximately 50 μg of the extracted protein was isolated by 10% (v/v) SDS-PAGE and transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore, Billerica, MA, USA) by electro-blotting. The membranes were then incubated with primary antibodies IL-1β (1:100), TNF-ɑ (1:100), MMP-13(1:100), caspase-3(1:100), BAX(1:100), β-catenin (1:100), FRZB (1:100), Wnt5a (1:100), LRP5/6 (1:100), and GSK-3β (1:100) for 2 d at 4°C; the primary antibodies were purchased from Boster Biological Technology. The membranes were washed with 1×TBST（Solarbio, Beijing, China）and incubated with an appropriate secondary antibody (Invitrogen, 1:2000) for 2 h. The immunoreactive bands were detected by exposing the blots in a multifunctional imager (GE, USA). The data were normalized against GAPDH for each protein.
Animal procedure A total of 30 SD male rats weighing 200-220 g were used. The rat OA model was established as described previously [31] , to measure the therapeutic effect of ART in vivo. All experimental procedures were performed in accordance with the Guidelines of the Animal Research Ethics Committee of the Guangxi Medical University. The SD rats received anterior cruciate ligament transection and medial meniscus resection (ACLT+MMx) at the right knee [31] . Briefly, all the rats in the experimental group were anesthetized with 2% pentobarbital sodium, followed by depilation, disinfection, and spreading of the towel, exposing the right knee joint through the medial patella incision. The patella was dislocated laterally and the knee was placed in the full flexion position, followed by ACL and MCL transection with micro-scissors and resection of the medial meniscus. The rats from the normal group were subjected to sham operations, in which the articular cavities were opened and sutured with the short anterior cruciate ligament intact. Four weeks after surgery, the rats were randomly assigned to two groups, and the ART group was injected with 0.1 mL of ART (4.0 μg/mL) into the articular cavity once a week. The OA group was injected with 0.1 mL of PBS as a control alone under the same conditions. After six weeks of therapy, all the rats were euthanized, followed by the collection of synovial fluid for enzyme-linked immunosorbent assay (ELISA) using the ELISA kit (R&D Systems, USA). The right knees were harvested for further examinations.
Macroscopic observation and histological analysis
Six weeks after the therapy, the rats were sacrificed and the knee joints were harvested. Macroscopic evaluation was performed by two blinded investigators (YJ and ZL). The erosion of articular cartilage was graded according to the macroscopic score system [32] , using a four-grade scale (0 = normal-appearing surface, 1 = minimal fibrillation or a slight yellow discoloration of the surface, 2 = erosion extending to the superficial or middle layers only, 3 = erosion extending to the deep layers, and 4 = erosion extending to the subchondral bone). A higher score indicated greater cartilage damage.
The histological evaluation was by Masson's trichrome staining. Briefly, after fixing with 4% (v/v) paraformaldehyde for 48 h and decalcifying with EDTA-decalcifying-fluid (Boster), the cartilage tissues were embedded in paraffin and cut into sections of thickness 3 μm. The sections were dewaxed and detected by Masson staining (Solarbio), according to the instructions. The examination and scoring of each section was performed by three independent researchers (YJ, ZL, and SW) individually. The Osteoarthritis Research Society International (OARSI) Cartilage Histopathology Assessment system was used to evaluate the degenerative status [33] .
Quantification of IL-1β, TNF-ɑ, BAX, and CASP-3 in vivo
The concentration of total IL-1β, TNF-ɑ, BAX, and CASP-3 in synovial fluid was determined using commercially available ELISA kits (R&D Systems), according to the manufacturer's instructions
Immunohistochemistry
The secretion of type II collagen (Col2a1), BAX, IL-1β, and CASP-3 was assayed by immunohistochemical staining. After washing with PBS, the cells and sections were exposed to 3% (v/v) hydrogen peroxide to block any endogenous peroxidase activity for 15 min at room temperature. The cells and sections were then blocked with normal goat serum for 20 min at room temperature and incubated with primary antibodies . The specimens were subsequently incubated with secondary antibody and biotinlabeled horse radish peroxidase. Antibody binding was then observed using the 3, 3′-diaminobenzidine tetrahydrochloride (DAB) kit (ZSGB-BIO, China), and then counterstained with hematoxylin. Eventually, the cells were gradually dehydrated, sealed with neutral resin, and observed and photographed with an inverted phase contrast microscope (Olympus BX53).
Statistical Analyses
The results are presented as mean ± standard deviation. The one-way analysis of variance was performed to determine significant differences, followed by post-hoc test (Turkey's t test). The level of significance was set to P < 0.05.
Results
Anti-inflammatory and chondro-protective effects of ART on IL-1β-induced rat chondrocytes in vitro
Preliminary Screening of ART. Preliminary screening of ART was conducted by the MTT assay. As illustrated in Fig. 1a , ART at concentrations of 0.007-14 µg/mL exhibited negligible cytotoxic effect. Artemisinin at concentrations of 0.125-4.0 µg/mL significantly improves the proliferation of cells (P < 0.05). Thus, 4.0 µg/mL was selected for further investigation; a similar concentration was also used in another study [18] .
Proliferation and viability. The proliferation of chondrocytes determined by the MTT assay in different groups is presented in Fig. 1b . Chondrocytes treated with IL-1β showed a decrease in proliferation (42.35%), which was enhanced by the pretreatment with ART (4.0 µg/mL). The IL-1β+ART group exhibited an increase of 38.63% compared with that of the IL-1β group at 48 h (P < 0.05).
The live/dead cell assay by FDA/PI staining revealed that the ART group had more viable cells (green) and less dead cells (red) than those in the IL-1β group (Fig. 1d) . This indicates that ART effectively protected the chondrocytes from IL-1β destruction, confirming the results of the MTT assay.
Osteoarthritis-related GAG loss. GAG secreted by intracellular chondrocytes was measured by the DMMB assay. As shown in Fig. 1c , chondrocytes exhibited a 55.98% decrease in GAG loss after treatment with IL-1β compared with that of the normal group. Artemisinin rescued GAG loss as evidenced by a 78.88% increase in GAG after treatment with ART compared with that of the IL-1β group at 48 h.
As shown in Fig. 1d , more intense staining with safranin O was observed in the IL-1β+ART group than in the IL-1β group, which was almost comparable to that in the normal control. The results suggested that the secretion of GAG increased after the treatment with ART, which is in accordance with the biochemical GAG secretion assays.
Expression of OA-related markers.
To investigate the anti-inflammatory and chondroprotective effects of ART on IL-1β-induced chondrocytes, qRT-PCR was performed to determine the gene expression level of inflammatory markers, including IL-1β, IL-6, TNF-ɑ, and MMP-13, and apoptotic markers BAX and caspase-3 ( Table 1 shows the sequence of primers sequences used in qRT-PCR). As shown in Fig. 1e , chondrocytes treated with IL-1β exhibited upregulated expression of IL-1β, IL-6, TNF-ɑ, MMP-13, BAX, and caspase-3 in IL-1β-treated cells. In contrast, ART prevented the IL-1β-mediated induction of IL-1β, IL-6, TNF-ɑ, and MMP-13, and simultaneously downregulated the expression of BAX and caspase-3 (P < 0.05). Western blotting further confirmed the qRT-PCR results, as evidenced by the downregulated expression of IL-1β, TNF-ɑ, MMP-13, caspase-3, and BAX compared with those in the IL-1β group ( Fig. 1f; Osteoarthritis-related GAG loss. GAG secretion by human OA chondrocytes treated with ART after 6 d was measured by the DMMB assay. As shown in Fig. 2c , ART promoted GAG secretion as evidenced by a 38.46% increase in GAG after treatment with ART compared with that in the OA group.
As shown Fig. 2d , OA chondrocytes showed less intense positive staining with safranin O than normal cells at each time point, which became more positive after treatment with ART, suggesting that the secretion of GAG increased after the treatment with ART.
Expression of OA markers on human chondrocytes.
To investigate the anti-inflammatory and chondro-protective effects of ART on human OA chondrocytes, qRT-PCR was performed to determine the expression level of IL-1β, IL-6, TNF-ɑ, MMP-13, BAX, and caspase-3. As shown in Fig. 2e , the expression of inflammatory markers, including IL-1β, IL-6, TNF-ɑ, and MMP-13, and apoptotic markers BAX and caspase-3 was significantly lower in the ART-treated group than in the OA group (P < 0.05), especially on days 4 6. The results indicated that ART inhibited the transcription of inflammatory and apoptotic genes.
The effects of ART on the expression level of OA-related proteins were investigated by WB. In the ART group, the expression of inflammatory markers IL-1β, TNF-ɑ, MMP-13, and apoptotic markers BAX and caspase-3 was significantly inhibited compared with those in the OA group (P < 0.05) (Fig. 2f) , which confirmed the qRT-PCR results.
The expression of IL-1β, TNF-ɑ, BAX, and caspase-3 proteins was detected by immunofluorescence (Fig. 2g) . Consistent with the results of qRT-PCR and WB, positive staining of IL-1β, TNF-ɑ, BAX, and caspase-3 was observed in the OA group, whereas, less intense staining was observed in the ART-treated groups. The results indicate that ART can effectively protect human chondrocytes from inflammation and apoptosis.
Effect of ART on ACLT+MMx-induced OA in vivo
Macroscopic observation. An experimental rat OA model fabricated by ACLT+MMx surgery was constructed to assess the effects of ART on the pathological development of OA. In the sham-operation (normal) group, the cartilage on the femoral condyles was normal with a smooth surface and no cartilage defects or osteophyte formation (Fig. 3a) . In the OA group, typical characteristics of OA, such as cartilage erosion and osteophyte formation, were observed on the side of the femoral condyles. With time, the damage to cartilage increased. However, the ART group showed less bone wear, cartilage erosion, and osteophyte formation than those in the OA group based on gross appearance in the same period. The macroscopic score of the ART groups reduced by 33.33% and 35.71% compared with that of the OA group at 3 and 6 weeks, respectively (Fig. 3b) .
Histopathological observation of the articular cartilage. The histopathological observation of cartilage in rats post-surgery included the surface abrasion of cartilage and thickness of cartilage. In the OA group, the apparent degeneration of cartilage was observed, as evidenced by massive loss of superficial cartilage, thinning of the cartilage from the femoral condyles and tibial plateaus, and the loss of proteoglycan (Fig. 3c) . However, ART significantly reduced Values are presented as the means ± SD, n = 5 joints, different letters denote s i g n i f i c a n c e s with P<0.05 and the same letter shows no significant differences (P ≥ 0.05).
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Fig. 4. A n t i a r t h r i t i c effect of ART on
c h o n d r o c y t e s via the Wnt/β-Catenin signaling pathway. (a) Western blot was used to analyze the proteins of Wnt5a, FRZB, GSK-3β and β-catenin and (b) qRT-PCR was performed to analyze the gene expression level of Wnt5a
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Cellular Physiology and Biochemistry cartilage destruction as evidence by alleviated cartilage structure damage, preserved matrix staining, and reduced number of abnormal cells, although osteophyte proliferation was not reversed (Fig. 3c) . The summed histologic score was used to assess cartilage degeneration, and the damage in the ART group was significantly lower than that in the OA group after 6 weeks of therapy (P < 0.05) (Fig. 3d) , which was consistent with the findings of macroscopic observation.
Expression of inflammatory and apoptotic markers in vivo.
In specimens of cartilage from the tibial plateau, chondrocytes in the superficial layers were detected by immunohistochemical staining of Col2a1, BAX, IL-1β, and CASP-3 (Fig. 3e) . More positive staining of Col2a1, a cartilage-specific marker, was observed in the ART group than in the OA group. However, in the OA group, large areas of strong positive staining of IL-1β, BAX, and β-catenin was observed in the middle and deep cartilage layers compared with those in the normal group. Less positive staining was observed in the shallow and middle cartilage layers, and most of the cartilage tissue remained intact in the ART group.
The expression level of inflammation and apoptosis markers in vivo after 6-weeks of treatment was also detected by the ELISA (Fig. 3f) . The expression of inflammatory markers IL-1β and TNF-ɑ, and apoptotic markers BAX and caspase-3 was significantly higher in the OA group than in the normal cartilage. After treatment with ART, the expression of IL-1β, TNF-ɑ, BAX, and caspase-3 was significantly reduced when compared with those in the OA group (P < 0.05). These results suggest that ART effectively ameliorated OA by downregulating inflammation and apoptosis in vivo.
Antiarthritic effect of ART via the Wnt/β-catenin signaling pathway
In IL-1β-induced rat chondrocytes, the expression of β-catenin, Wnt5a, and GSK-3β was upregulated, whereas that of FRZB was downregulated compared with those in the normal group (Fig. 4a ). After treatment with ART, the expression of β-catenin, Wnt5a, and GSK-3β was significantly downregulated and FRZB was upregulated. Lithium chloride promoted β-catenin translocation to the nucleus to activate the Wnt/β-Catenin signaling pathway and effectively promoted the expression of GSK-3β, Wnt5a, and LRP5/6. However, ART reduced the expression of Wnt5a, GSK-3β, LRP5/6, and β-catenin increased by IL-1β+LiCl and increased the expression of FRZB (Fig. 4b) .
In human-derived OA chondrocytes, the expression of Wnt5a, GSK-3β, and LRP5/6 was upregulated and FRZB was downregulated compared with those in the normal human chondrocytes (Fig. 4c) . As expected, ART reduced the expression of Wnt5a, GSK-3β, LRP5/6, and β-catenin increased by LiCl and increased the expression of FRZB in human chondrocytes (Fig. 4d) . These results indicate that ART ameliorates osteoarthritis by suppressing the Wnt/ β-Catenin signaling pathway.
Discussion
Currently, NSAIDs are the main clinically used drugs for OA. However, NSAIDs are limited by their side effects, such as ease of suppression, limited clinical remission rate, and immunity [3] . Due to the minimal side effects and potent anti-inflammatory activity, ART is used to treat OA in the present study.
Artemisinin exhibited potent anti-inflammatory effect by inhibiting the expression of pro-inflammatory chemokines and cytokines, such like IL-1β, IL-6, TNF-ɑ, and MMP-13, in both IL-1β-induced OA chondrocytes of rats and cells derived from patients with OA ( Fig. 1e-g, Fig. 2e-g ). It also ameliorated ACLT-injured cartilage degradation by downregulating the expression of inflammatory markers (IL-1β and TNF-ɑ) (Fig. 3f) . Interleukin-1β and TNF-ɑ are predominant cytokines regulating the production of multifarious pro-inflammatory cytokines, such as IL-6 and IL-8, for the initiation of inflammation cascades [34] . These cytokines also function as catabolic factors in cartilage destruction via the activation of Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry proteinases (MMPs and aggrecanases) [35] . MMP-13 is a major enzyme responsible for the degradation of type II collagen in OA [36] . In the present study, ART downregulated the expression of pro-inflammatory cytokines elevated in IL-1β-treated chondrocytes and ACLTstimulated joints (Fig. 1e, Fig. 2e, Fig. 3f.) , which effectively reduced the expression of MMPs and rescued the subsequent degradation of articular cartilage matrix. It also decreased the expression of inflammatory markers in OA patient-derived chondrocytes, which holds promise in OA therapy. Artemisinin has favorable biocompatibility and chondro-protective potential as evidenced by enhanced cell proliferation and viability, and GAG deposition in both IL-1β-treated (Fig. 1b-d) and human OA-derived chondrocytes (Fig. 2a-d) . It has been reported that ART has minimal cytotoxicity against normal cells [37] . Artemisinin also prevented ACLT-induced cartilage degradation by upregulating the expression of cartilage specific marker Col2a1. The chondro-protective effect of ART might be associated with its role in the prevention of chondrocyte apoptosis. Accumulating evidence suggests that chondrocyte apoptosis plays an important role in the development and progression of OA [38, 39] . During the repair process, the apoptotic cells represented by an increased survival of chondrocytes might be a protection mechanism. Upon activation of apoptosis, ART leads to the stimulation of caspase cascade, including caspase-2, caspase-3, and caspase-9, and subsequently the cellular components are dismantled resulting in cell death [40, 41] . The extrinsic pathway is induced by death receptor signaling ligands, such as FasL, TNFa, and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) [42] . TRAIL determines the activation of the extrinsic pathway, and bind to its death receptors DR4 and DR5 and induce caspase-8 initiator protease, which activates executioner proteases, such as caspase-3 [43] . In the present study, we observed that ART blocked chondrocyte apoptosis as evidenced by the downregulation of expression of intrinsic pathway markers BAX and caspase-3 ( Fig. 1e-g,  Fig. 2e-g ), demonstrating the chondro-protective potential of ART.
Notably, Wnt/β-catenin signaling, which contributes to the extracellular matrix damage process and chondrocyte destruction in the etiology and pathogenesis of OA [22, 23] , was effectively inhibited by ART. Some FDA-approved drugs, such as verapamil, are Wnt antagonists which hold promise in OA therapy [44] . FRZB, an original antagonist of Wnt signaling [25] identified as a chondrogenic factor in articular cartilage extracts, has been studied in OA animal models and patients with OA as a modulator of Wnt signaling [23] . In the present study, ART markedly inhibited the activation of Wnt/ β-catenin signaling as evidenced by the upregulation of FRZB in IL-1β-induced chondrocytes and downregulation of the expression of β-catenin (Fig. 5) chemokines, and apoptosis-related factors in human OA chondrocytes [45] . Accompanied with the downregulation of β-catenin, the expression of GSK-3β, Wnt5a, and LRP5/6 was downregulated. Artemisinin also rescued the matrix damage process and aggravated chondrocyte destruction by LiCl, which is an activator of Wnt/β-catenin signaling pathway that can upregulate the expression of β-catenin, GSK-3β, Wnt5a, and LRP5/6. These results indicate that ART might inactivate Wnt/β-catenin signaling. They also confirm that ART serves as a favorable Wnt/β-catenin antagonist to protect chondrocytes from destruction in patients with OA. We also demonstrated that ART derived from natural herbs exerted antiinflammatory and chondro-protective effects in the treatment of IL-1β-induced chondrocytes and OA patient-derived chondrocytes. It also protected cartilage from the destruction in ACLT-injured joints. The effect of ART on OA might be associated with the inhibition of Wnt/ β-catenin signaling pathway. The results of the present study suggest the potential of ART in the treatment of OA.
Conclusion
In conclusion, ART alleviates IL-1β-mediated inflammatory response and OA progression by regulating the Wnt/β-catenin signaling pathway. Thereby, it might be developed as a potential therapeutic agent for OA. However, the effect and mechanism of action of ART should be further explored, as the present study was limited in terms of number of animals, OA score, etc. Especially, the clinical application of ART should be investigated.
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